Dr.Jothydev Kesavadev was the speaker of ADA Primer 2020 convention on 3 October 2020 organized by Dr.Aravind Sosale. He spoke on 'FDA approved biosimilar insulins'- development and need of biosimilars, as a cost effective solution to save millions of precious lives; and on Biocon biosimilar glargine. The session was moderated by Dr.Anand Moses.